Mesa Laboratories Valuation
| MLAB Stock | USD 93.46 4.83 5.45% |
At this time, the firm appears to be fairly valued. Mesa Laboratories secures a last-minute Real Value of $90.1 per share. The latest price of the firm is $93.46. Our model forecasts the value of Mesa Laboratories from analyzing the firm fundamentals such as Current Valuation of 652.5 M, profit margin of 0.02 %, and Return On Equity of 0.0218 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mesa Laboratories' valuation include:
Price Book 2.6806 | Enterprise Value | Enterprise Value Ebitda 13.1273 | Price Sales 1.9781 | Forward PE 35.2113 |
Fairly Valued
Today
Please note that Mesa Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Mesa Laboratories is based on 3 months time horizon. Increasing Mesa Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mesa Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mesa Stock. However, Mesa Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 93.46 | Real 90.1 | Target 104.5 | Hype 91.68 | Naive 96.51 |
The real value of Mesa Stock, also known as its intrinsic value, is the underlying worth of Mesa Laboratories Company, which is reflected in its stock price. It is based on Mesa Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mesa Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mesa Laboratories helps investors to forecast how Mesa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mesa Laboratories more accurately as focusing exclusively on Mesa Laboratories' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mesa Laboratories' intrinsic value based on its ongoing forecasts of Mesa Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mesa Laboratories' closest peers. If more than one evaluation category is relevant for Mesa Laboratories we suggest using both methods to arrive at a better estimate.
Mesa Laboratories Cash |
|
Mesa Revenue by Product
Mesa Laboratories Total Value Analysis
Mesa Laboratories is now forecasted to have valuation of 652.5 M with market capitalization of 489.66 M, debt of 181.47 M, and cash on hands of 43.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mesa Laboratories fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
652.5 M | 489.66 M | 181.47 M | 43.75 M |
Mesa Laboratories Investor Information
About 85.0% of the company shares are owned by institutional investors. The book value of Mesa Laboratories was now reported as 33.79. The company has Price/Earnings (P/E) ratio of 433.94. Mesa Laboratories last dividend was issued on the 27th of February 2026. Based on the key indicators related to Mesa Laboratories' liquidity, profitability, solvency, and operating efficiency, Mesa Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 56.5 M | 53.8 M |
|
|
Mesa Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mesa Laboratories has an asset utilization ratio of 55.61 percent. This suggests that the Company is making $0.56 for each dollar of assets. An increasing asset utilization means that Mesa Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Mesa Laboratories Profitability Analysis
Based on Mesa Laboratories' profitability indicators, Mesa Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Mesa Laboratories' ability to earn profits and add value for shareholders.Net Loss | First Reported 1989-09-30 | Previous Quarter 2.5 M | Current Value 3.6 M | Quarterly Volatility 21.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.69 | 0.72 |
|
|
For Mesa Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mesa Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mesa Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mesa Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mesa Laboratories over time as well as its relative position and ranking within its peers.
Mesa Laboratories Earnings per Share Projection vs Actual
By analyzing Mesa Laboratories' earnings estimates, investors can diagnose different trends across Mesa Laboratories' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Mesa Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.Mesa Laboratories Ownership Allocation
The market capitalization of Mesa Laboratories is $489.66 Million. The majority of Mesa Laboratories outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mesa Laboratories to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mesa Laboratories. Please pay attention to any change in the institutional holdings of Mesa Laboratories as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Mesa Laboratories Profitability Analysis
The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 154.48 M.Mesa Laboratories Past Distributions to stockholders
| 15th of December 2025 | ||
| 15th of September 2025 | ||
| 16th of June 2025 | ||
| 17th of March 2025 | ||
| 16th of December 2024 | ||
| 16th of September 2024 | ||
| 14th of June 2024 | ||
| 15th of March 2024 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mesa Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mesa Laboratories and how it compares across the competition.
About Mesa Laboratories Valuation
The stock valuation mechanism determines Mesa Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Mesa Laboratories. We calculate exposure to Mesa Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mesa Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 173.5 M | 182.2 M | |
| Pretax Profit Margin | 0.03 | 0.03 | |
| Operating Profit Margin | 0.08 | 0.07 | |
| Net Loss | (0.01) | (0.01) | |
| Gross Profit Margin | 0.72 | 0.69 |
A single share of Mesa Laboratories represents a small ownership stake in the entity. As a stockholder of Mesa, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Mesa Laboratories Dividends Analysis For Valuation
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 7.91, whereas Dividends Paid is projected to grow to (3 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 3.97, whereas Retained Earnings are projected to grow to (206.4 M).
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -3.1 M | -3 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | (1.58) | (1.50) | |
| Dividend Paid And Capex Coverage Ratio | 6.76 | 7.91 |
There are various types of dividends Mesa Laboratories can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Mesa shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Mesa Laboratories directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Mesa pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Mesa Laboratories by the value of the dividends paid out.
Mesa Laboratories Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 5.4 M | |
| Quarterly Earnings Growth Y O Y | -0.287 | |
| Forward Price Earnings | 35.2113 |
Mesa Laboratories Current Valuation Indicators
Valuation refers to the process of determining the present value of Mesa Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mesa we look at many different elements of the entity such as Mesa's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mesa Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mesa Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mesa Laboratories' worth.Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |